Take a seat in the front row and listen as some of the world’s foremost scientists introduce you to innovative medicines and treatments.

Advancing the vision: An experiment in rethinking the nonprofit biomedical research model with Peter Schultz, PhD

In his Front Row lecture, President and CEO Peter Schultz will highlight the progress Scripps Research has made in pioneering a new model for non-profit biomedical research. He will describe how integrating basic science and translational research under one roof is accelerating next-generation medicines—from new immunotherapies for cancer and innovative medicines for infectious disease to regenerative treatments for heart, lung, and intestinal tissues. At a time of uncertainty in federal science funding, this model is not only advancing human health but also helping to generate sustainable support for innovative scientific research and for training the next generation of scientific leaders. Learn more at frontrow.scripps.edu.

About Scripps Research

Committed to unraveling the intricacies of the human body and translating our discoveries into tangible global impact, Scripps Research is consistently ranked among the most influential non-profit research institutes in the world. Throughout our 100-year history, our scientists have expanded the boundaries of scientific understanding and played a pivotal role in the development of 18 FDA-approved medicines that have impacted the lives of countless individuals worldwide.

The Front Row lecture series, now in its ninth season, offers an exclusive glimpse into groundbreaking scientific discoveries in action. Many of these breakthroughs are the result of years of tireless work—made possible by the support of our community.

As we enter another century of science changing life at Scripps Research, our focus remains the same: fueling world-class fundamental and translational research to accelerate the development of medical advances for the benefit of human health.